The Latest Breaking News from Jazz

While Palatin Technologies (PTN) has faced challenges with declining share price, negative analyst projections, and limited profitability, it's worth noting the consistent growth in the broader biotech industry. Thus, investors could find more stable returns in robust biotech stocks Protalix BioTherapeutics (PLX), Exelixis (EXEL), and Jazz Pharmaceuticals (JAZZ) instead. Read…

The revolution is underway in Salt Lake City, Utah.

From Boston to Los Angeles and every franchise in between, here’s when the #Rockets will face each NBA team during the 2023-24 season.

Breaking down the entire 2023-24 regular season schedule for the Thunder:

Here’s the full #Rockets schedule for the 2023-24 NBA regular season, including dates and locations, tipoff times, and broadcast information. It all begins on Wednesday, Oct. 25, in Orlando.

SEG Media will use use Kiswe’s cloud-based video solutions and the NBA’s streaming platform to stream Utah Jazz games

The biotech industry is well-positioned for solid growth, thanks to the rising need for high-quality healthcare and the government's push to increase domestic biotech production and research. To that end, buying fundamentally strong biotech stocks Gilead Sciences (GILD) and Jazz Pharmaceuticals (JAZZ) could be wise. However, it could be prudent…

The biotech industry is ascending with growing R&D initiatives, an upsurge in personalized medicine, and enhanced drug formulations, coupled with the incorporation of technological advancements. So, it seems wise to invest in discounted biotech stocks Vertex Pharmaceuticals (VRTX), Jazz Pharmaceuticals (JAZZ), and Alkermes (ALKS) this month. Keep reading….

Utah wasn’t close to being a playoff team, but with new core players like Lauri Markkanen stepping up to the plate, the squad’s progression is worth a look.